| EP1807091 - NOVEL USE OF LIGANDS SPECIFIC TO FEX-2 POLYPEPTIDE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.09.2009 Database last updated on 11.04.2026 | Most recent event Tooltip | 25.09.2009 | Application deemed to be withdrawn | published on 28.10.2009 [2009/44] | Applicant(s) | For all designated states Kyungpook National University Industry- Academic Cooperation Foundation Kyungpook National University Sangyeok 3-dong, Book-gu Daegu 702-701 / KR | [2007/29] | Inventor(s) | 01 /
KIM, In-San Dongseo Town, 106-908 Maeho-dong, Suseong-gu Daegu 706-140 / KR | 02 /
PARK, Seung-Yoon Cheongwoo Apt., 301-1912 Hwangseong-dong, Gyeongju Gyeongbuk 780-761 / KR | 03 /
JUNG, Mi-Yeon 101, 46-1, Dongin 3-ga, Joong-gu Daegu 700-423 / KR | 04 /
KIM, Ha-Jeong Daedeok Mansion, 206-701 Bondeok 3-dong, Nam-gu Daegu 705-023 / KR | [2007/29] | Representative(s) | Bockhorni & Brüntjen Partnerschaft Patentanwälte mbB Agnes-Bernauer-Straße 88 80687 München / DE | [N/P] |
| Former [2008/31] | Bockhorni & Kollegen Elsenheimerstrasse 49 80687 München / DE | ||
| Former [2007/29] | GROSSE BOCKHORNI SCHUMACHER Patent- und Rechtsanwälte Elsenheimerstrasse 49 80687 München / DE | Application number, filing date | 05856534.2 | 12.10.2005 | [2007/29] | WO2005KR03404 | Priority number, date | KR20040081499 | 12.10.2004 Original published format: KR 20040081499 | [2007/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006080757 | Date: | 03.08.2006 | Language: | EN | [2006/31] | Type: | A1 Application with search report | No.: | EP1807091 | Date: | 18.07.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.08.2006 takes the place of the publication of the European patent application. | [2007/29] | Search report(s) | International search report - published on: | KR | 03.08.2006 | Classification | IPC: | A61K31/685, A61P37/06 | [2007/29] | CPC: |
A61K31/685 (EP,KR,US);
A61K38/02 (KR);
A61K39/395 (KR);
A61P1/04 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P19/06 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P29/02 (EP);
A61P3/06 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P37/06 (EP);
A61P5/10 (EP);
A61P5/18 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/29] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | NEUE VERWENDUNG VON FEX2-POLYPEPTID-SPEZIFISCHEN LIGANDEN | [2007/29] | English: | NOVEL USE OF LIGANDS SPECIFIC TO FEX-2 POLYPEPTIDE | [2007/29] | French: | NOUVELLE UTILISATION DE LIGANDS SPECIFIQUES AU POLYPEPTIDE FEX-2 | [2007/29] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 27.04.2007 | National basic fee paid | 27.04.2007 | Search fee paid | 27.04.2007 | Designation fee(s) paid | 27.04.2007 | Examination fee paid | Examination procedure | 11.08.2006 | Request for preliminary examination filed International Preliminary Examining Authority: KR | 27.04.2007 | Examination requested [2007/29] | 05.07.2007 | Amendment by applicant (claims and/or description) | 05.05.2009 | Application deemed to be withdrawn, date of legal effect [2009/44] | 15.06.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2009/44] | Fees paid | Renewal fee | 29.10.2007 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.10.2008 | 04   M06   Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XP] HOFFMANN ET AL.: "Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo", J. IMMUNOL., vol. 174, no. 3, February 2005 (2005-02-01), pages 1393 - 1404, XP003017529 [XP] | [XP] OTSUKA ET AL.: "Phosphatidylserine-specific receptor contributes to TGF-beta production in macrophages through a MAP kinase, ERK", BIOL. PHARM. BULL., vol. 28, no. 9, September 2005 (2005-09-01), pages 1707 - 1710, XP003017530 [XP] DOI: http://dx.doi.org/10.1248/bpb.28.1707 | [X] GAIPL ET AL.: "Exposure of anionic phospholipids serve as anti-inflammatory and immunosuppresive signal implications for antiphospholipid syndrome and systemic lupus erythematosus", IMMUNOBIOLOGY, vol. 207, no. 1, 2003, pages 73 - 81, XP009009808 [X] DOI: http://dx.doi.org/10.1078/0171-2985-00217 | [X] HUYNH ET AL.: "Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation", J. CLIN. INVEST., vol. 109, no. 1, 2002, pages 41 - 50, XP003017531 [X] DOI: http://dx.doi.org/10.1172/JCI200211638 | [X] MATSUNO ET AL: "Involvement of TGF-beta in inhibitory effects of negatively charged liposomes on nitric oxide production by macrophages stimulated with LPS", BIOCHEM. BIOPHYS. RES. COMM., vol. 281, no. 3, 2001, pages 614 - 620, XP003017532 [X] DOI: http://dx.doi.org/10.1006/bbrc.2001.4419 |